ClearPoint Neuro partners with pharmaceutical and biologics companies through all stages of therapy development, leveraging our FDA-cleared and CE marked solutions for direct CNS infusions.*  ClearPoint offers services, devices, and software to enable MRI-guided intraparenchymal and CSF delivery of gene, cell, and other therapies.  Our team has the expertise to guide you from the benchtop, into pre-clinical studies, through clinical trials, and onto post-commercialization with translational continuity.  We aim to provide an industry-leading cadence of innovation and caliber of services – all fully customizable to meet your program’s needs.

* Visit the ClearPoint Neuro website for more information on the SmartFlow Cannula’s regulatory clearance.